Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment

ClinicalTrials.gov ID: NCT02809118

Public ClinicalTrials.gov record NCT02809118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02809118
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Auris Medical, Inc.
Industry
Enrollment
56 participants

Conditions and interventions

Interventions

  • AM-111 0.4 mg/ml Drug
  • AM-111 0.8 mg/ml Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2016
Primary completion
Jan 31, 2018
Completion
Jan 31, 2018
Last update posted
Aug 6, 2020

2016 – 2018

United States locations

U.S. sites
38
U.S. states
21
U.S. cities
37
Facility City State ZIP Site status
Not listed Birmingham Alabama 35294-0012
Not listed Escondido California 92025
Not listed Fresno California 93720
Not listed La Jolla California 92037-1214
Not listed Aurora Colorado 80045
Not listed New Haven Connecticut 06519
Not listed Boca Raton Florida 33487
Not listed Boynton Beach Florida 33426-6398
Not listed Celebration Florida 34747
Not listed Miami Florida 33133
Not listed Miami Florida 33176
Not listed Port Saint Lucie Florida 34952
Not listed Chicago Illinois 60657
Not listed Des Moines Iowa 50312
Not listed Kansas City Kansas 66160
Not listed Louisville Kentucky 40207
Not listed Novi Michigan 48374
Not listed Columbia Missouri 65212
Not listed Lebanon New Hampshire 03756
Not listed Charlotte New York 28210
Not listed New Hyde Park New York 11042-1121
Not listed New Windsor New York 12553
Not listed New York New York 10032
Not listed Rochester New York 14618
Not listed White Plains New York 10601-4413
Not listed Matthews North Carolina 28105
Not listed Winston-Salem North Carolina 27103-1522
Not listed Havertown Pennsylvania 19083
Not listed Philadelphia Pennsylvania 19107
Not listed Charleston South Carolina 29425
Not listed Lugoff South Carolina 29078
Not listed Orangeburg South Carolina 29118
Not listed Nashville Tennessee 37232-8605
Not listed Fort Sam Houston Texas 78234
Not listed Salt Lake City Utah 84102
Not listed St. George Utah 84790
Not listed Norfolk Virginia 23507
Not listed Tacoma Washington 98431-1100

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02809118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02809118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →